期刊
SEMINARS IN FETAL & NEONATAL MEDICINE
卷 22, 期 6, 页码 383-390出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.siny.2017.11.002
关键词
Congenital diaphragmatic hernia; Prenatal therapy; Pulmonary hypoplasia; Pulmonary hypertension; Sildenafil
类别
资金
- GOSH Children's Charity
- Engineering and Physical Sciences Research Council [NS/A000027/1]
- Innovative Engineering for Health - Wellcome Trust [WT101957]
- UCL/UCLH NIHR Biomedical Research Centre [IS-BRC-1215-20012]
- GOSHCC
- GOSH NIHR Biomedical Research Centre's funding scheme
- Catapult Cell Therapy
- Fetal Health Foundation (USA) [ZKD2426, O6510]
- Sparks
- Erasmus + Programme of the European Commission [2013-0040]
- CDHUK
- National Institute for Health Research [RP_2014-04-046] Funding Source: researchfish
Congenital diaphragmatic hernia is surgically correctable, yet the poor lung development determines mortality and morbidity. In isolated cases the outcome may be predicted prenatally by medical imaging. Cases with a poor prognosis could be treated before birth. However, prenatal modulation of lung development remains experimental. Fetoscopic endoluminal tracheal occlusion triggers lung growth and is currently being evaluated in a global clinical trial. Prenatal transplacental sildenafil administration may in due course be a therapeutic approach, reducing the occurrence of persistent pulmonary hypertension, either alone or in combination with fetal surgery. (C) 2017 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据